Why đ” UnitedStatesNews-NoOpEd picked: To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such âpostmarketâ studies are behind schedule or overdue, records show.
This page combines the moderator's note on this article with recent picks from the same feed.
Source: bsky.app
Lead moderator note on this article
This is a report on the FDA allowing companies to conduct postmarket drug and device studies in the United States.
Additional moderation notes
đ” UnitedStatesNews-NoOpEd
This is a report on the FDA allowing companies to conduct postmarket drug and device studies in the United States.
What this feed curates
United States news only, filter opinion pieces
Topics: TOP_STORIES, GENERAL_NEWS, BUSINESS, POLITICS, US
Recent picks from this moderator
Trump Moves Ahead With F-35 Jet Sales to Saudi Arabia Despite Intelligence Concerns
This covers major strategic policy developments and international arms sales impacting Middle Eastern regional stability.
Lawyers representing Rep. Joyce Beatty, a Kennedy Center trustee, argued that images show President Trump is âactively considering demolition of the entire structure.â They asked the court to make âcrystal clear that its order prohibits demolishingâ it. https://wapo.st/4dIbx2x
Here is a news story regarding legal developments in the United States concerning the Kennedy Center.
The US Institute of Peace asked a federal appeals court for emergency relief to prevent the administration from carving President Donald Trumpâs name into the facade of its headquarters which was renamed for him last year.